1. Specifications table {#s0005}
=======================

Subject areaBiochemistry, Materials chemistryMore specific subject areaSurface ProteomicsType of dataText file, figureHow data was acquiredX-ray diffraction, mass spectrometry, and fluorescence spectroscopyData formatAnalyzedExperimental factorsThe SiO~2~\@Fe~3~O~4~ MNPs were modified with NHS ester groups via a cleavable ester bond. Quantitative fluorometric characterization of ester linked NHS ester modified SiO~2~\@Fe~3~O~4~ MNPs was performed to determine active NHS ester sites on the surface of SiO~2~\@Fe~3~O~4~ MNPs. Solvent exposed free amine residues of peptides were labeled using cleavable ester linked NHS ester linked silica coated iron oxide magnetic nanoparticles. The labeling reaction was performed under physiological conditions to preserve the native structure of proteins. The ester bond was subsequently cleaved followed by magnetic separation of nanoparticlesExperimental featuresThe label generated on the solvent exposed free amine groups of peptides and proteins were identified by mass spectrometric analysis.Data source locationNew Orleans, Louisiana, USAData accessibilityData is included in this article

2. Value of the data {#s0010}
====================

•The surface exposed amine groups of peptides can be determined by labeling with ester linked NHS ester modified SiO~2~\@Fe~3~O~4~ MNPs under physiological conditions.•Cleavable ester linked NHS ester modified SiO~2~\@Fe~3~O~4~ MNPs provide an effective approach to magnetically separate the labeled peptides from the solution without adding extra step of purification.•The flurometric quantification of active NHS ester sites on the surface of SiO~2~\@Fe~3~O~4~ MNPs can allow quantitative control over the labeling reaction.

3. Data, experimental design and methods {#s0015}
========================================

The data shown here is divided into four major steps: a) synthesis and characterization of SiO~2~\@Fe~3~O~4~ MNPs, b) synthesis of ester linked NHS ester modified SiO~2~\@Fe~3~O~4~ MNPs, c) fluorometric quantification of active NHS ester sites on the surface of SiO~2~\@Fe~3~O~4~ MNPs and, d) labeling and identification of primary amine groups of ACTH (4--11) using ester linked NHS ester modified SiO~2~\@Fe~3~O~4~ MNPs.

4. Materials and methods {#s0020}
========================

Iron (III) oxyhydroxide (FeO(OH)), oleic acid, dimethyl sulfoxide (DMSO, anhydrous), (3-aminopropyl)triethoxysilane (APTES, 95%), tetraethylorthosilicate (TEOS, 99%), Igepal CO-520, cyclohexane, dansylcadaverine, ≥97%, hydroxylamine hydrochloride, bovine serum albumin (BSA) and β-lactoglobulin were purchased from Sigma-Aldrich (St. Louis, MO). 1-Octadecene was purchased from Alfa Aesar (Ward Hill, MA). Ethylene glycolbis(succinimidylsuccinate) (EGS, +99%) was purchased from ProteoChem (Loves Park, IL). Phosphate buffered saline (PBS) was purchased from Calbiochem (Billerica, MA). Dithiothreitol and iodoacetamide were purchased from Piercenet, Thermo Scientific (Rockford, IL). ACTH (4--11) was purchased from American Peptide Company (Sunnyvale,CA). Ethanol was purchased from Pharmco-AAPER (Brookefield,CT). Nanopure, deionized and distilled water (18.2 MΩ) was used for all experiments. Fluorescence measurements were performed by using Agilent Cary Eclipse fluorescence spectrophotometer (Santa Clara, CA).

5. Experimental design and data {#s0025}
===============================

5.1. Synthesis of iron oxide nanoparticles {#s0030}
------------------------------------------

Iron oxide nanoparticles were synthesized as described [@bib2] and characterized by XRD ([Fig. 1](#f0005){ref-type="fig"}).

5.2. Silica coating of Fe~3~O~4~ MNPs by reverse micro-emulsion approach (scheme 1) {#s0035}
-----------------------------------------------------------------------------------

Silica coating was performed as reported earlier. [@bib3] The Fe~3~O~4~ MNPs (400 µL of 10 mg/mL) were dissolved in cyclohexane (4 mL) and Igepal-CO-520 (0.247 g) then sonicated for 15 min. The suspension was further mixed with tetraethyorthosilicate (25 µL) and sonicated again for 10 min. In the last step, ammonium hydroxide (50 µL) was added and sonicated for 15 min. The suspension was stirred using a magnetic stirrer at room temperature for 24 h. The SiO~2~\@Fe~3~O~4~ MNPs were magnetically recovered, washed using ethanol several times, and dried at room temperature.

Scheme 1: synthesis of cleavable ester linked, NHS ester modified SiO~2~\@Fe~3~O~4~ MNPs

5.3. Functionalization of SiO~2~\@Fe~3~O~4~ MNPs with amine groups (scheme 1) {#s0040}
-----------------------------------------------------------------------------

Amine groups were introduced on the surface of SiO~2~\@Fe~3~O~4~ MNPs using amine containing silane coupling reagent [@bib4]. The SiO~2~\@Fe~3~O~4~ MNPs (10 mg) were resuspended in ethanol (10 mL) followed by 20 min of sonication. In the next step, APTES (95%, 100 μL) was added dropwise and the mixture was mechanically stirred at room temperature for 24 h. Amine modified Fe~3~O~4~ SiO~2~\@Fe~3~O~4~ MNPs were magnetically separated, washed several times with ethanol, and air dried at room temperature.

5.4. Synthesis of cleavable linked, NHS ester modified SiO~2~\@Fe~3~O~4~ MNPs (scheme 1) {#s0045}
----------------------------------------------------------------------------------------

Amine modified SiO~2~\@Fe~3~O~4~ MNPs (1 mg) were mixed with ethanol (100 μL), followed by sonication for 10 min. EGS (12 mg in μL DMSO, 100 final conc. 0.13 M) was added dropwise to the solution of amine modified SiO~2~\@Fe~3~O~4~ MNPs and allowed to react for 20 min at room temp. EGS modified SiO~2~\@Fe~3~O~4~ MNPs were recovered by magnetic separation, washed with ethanol, and dried under vacuum.

Presence of NHS ester was determined by conjugating dansylcadaverine and mesuring the fluoscence of dansylcadaverine conjugated SiO~2~\@Fe~3~O~4~ MNPs.

5.5. Labeling amine groups of peptides/proteins using cleavable ester linked, NHS ester modified SiO~2~\@Fe~3~O~4~ MNPs {#s0050}
-----------------------------------------------------------------------------------------------------------------------

Labeling of ACTH (4--11), BSA and β-lactoglobulin was performed by following a protocol as reported earlier [@bib5] with minor modifications. Protein sample (BSA or β-lactoglobulin, 10 μL, 10 mg/mL) solution was mixed with ester cleavable, NHS ester modified SiO~2~\@Fe~3~O~4~ MNPs followed by addition of PBS, pH=7.4 (190 μL). The mixture was allowed to stir at room temperature for 40 min. Protein conjugated SiO~2~\@Fe~3~O~4~ MNPs were magnetically separated and washed with water (6X). The unreacted NHS ester groups on the surface of SiO~2~\@Fe~3~O~4~ MNPs were quenched by reacting with Tris--HCl (100 μL of 50 mM) for 15 min followed by washing with water (3X). Protein conjugated SiO~2~\@Fe~3~O~4~ MNPs were incubated with urea (8 M, aq. 80 μL) and DTT (5 μL of 200 mM) at 45˚C for 1 h. Free thiol groups were alkylated with iodoacetamide (10 μL of 200 mM) for 1 h in the dark. Trypsin was added (6 μg) with ammonium bicarbonate (1 mL of 50 mM) followed by digestion for 15 h at 37 °C. The tryptic peptide conjugated SiO~2~\@Fe~3~O~4~ MNPs were magnetically separated and washed with water (3X), and water:ACN (30:70, 6X). Labeled tryptic peptides were isolated from SiO~2~\@Fe~3~O~4~ MNPs by cleaving the ester bond using hydroxylamine (200 μL of 2 M, pH=8.5) for 4 h at 37 °C. The SiO~2~\@Fe~3~O~4~ MNPs were magnetically separated, and the supernatant was saved for further analysis [Fig. 2](#f0010){ref-type="fig"}.

The mass spectra of a doubly charged, both amine modified ACTH (4--11) is shown in [Fig. 3](#f0015){ref-type="fig"}. The b and y ion were manually calculated and matched with major peaks in the spectra.

5.6. Mass spectrometric analysis of labeled ACTH (4--11), BSA and β-lactoglobulin {#s0055}
---------------------------------------------------------------------------------

Chromatographic separation was performed by using a chip consisting of a 160 nL enrichment column and a 150 mm analytical column packed with C18, 5 m beads with 300 Å pores. The sample (2 μL) was transferred to the enrichment column via the capillary pump. Capillary pump was operated at a flow rate of 4 μL/min. The flow rate of nano pump was set to 600 nL/min. The MS source was operated at 300 °C with 5 L/min N~2~ flow and a fragmentor voltage of 175 V. Quad and TOF were operated in the positive ion mode. The calibration standards contained reference compounds of 322.048121 and 1221.990637 Da, which were continually released into the source for mass calibration. LC chromatograms and mass spectra were analyzed using Mass-Hunter software (Version B.0301; Agilent Technologies).

5.7. Quantification of active NHS ester groups on the surface of SiO~2~\@Fe~3~O~4~ MNPs using 'depletion' approach {#s0060}
------------------------------------------------------------------------------------------------------------------

Cleavable ester linked, NHS ester modified SiO~2~\@Fe~3~O~4~ MNPs were prepared as shown in [Scheme 1.](#f0025){ref-type="fig"} Dansylcadaverine (700 μL of 20 μM) was mixed with cleavable ester linked, NHS ester modified SiO~2~\@Fe~3~O~4~ MNPs (1 mg) for 40 min. The dansylcadaverine conjugated SiO~2~\@Fe~3~O~4~ MNPs were magnetically separated, and the supernatants were collected for quantitative fluorescence measurements ([Fig. 4](#f0020){ref-type="fig"}). The quantity of conjugated dansylcadaverine was determined by subtracting the quantity of remaining dansylcadaverine after conjugation to NHS ester modified SiO~2~\@Fe~3~O~4~ MNPs from the initial quantity of dansylcadaverine.
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![XRD data of Fe~3~O~4~ MNPs.](gr1){#f0005}

![Fluorescence spectra of dansylcadaverine conjugated SiO~2~\@Fe~3~O~4~ MNPs.](gr2){#f0010}

![MS/MS spectra of doubly charged ACTH (4--11) with both amine labeled (*m*/*z*=660.7) by cleavable ester linked, NHS ester modified SiO~2~\@Fe~3~O~4~ MNPs.](gr3){#f0015}

![Fluorescence spectra of danylcadaverine before conjugation to cleavable ester linked NHS ester modified SiO~2~\@Fe~3~O~4~ MNPs (blue) and danylcadaverine after conjugation to cleavable ester linked NHS ester modified SiO~2~\@Fe~3~O~4~ MNPs (red).](gr4){#f0020}
